BioHiTech Global Cash Flow - Quarterly (OTCMKTS:BHTG)

Add to My Stocks
$7.3 $0.3 (3.95%) BHTG stock closing price Aug 18, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like BioHiTech Global needs to disclose. While its important to look at the BioHiTech Global debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as BioHiTech Global revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. The cash flow statement helps in the BioHiTech Global stock analysis by providing more information for evaluating changes in assets, liabilities and equities. BHTG decrease in investments stood at a negative value of $-1.1M for the latest 2017-Q2. View details of BioHiTech Global cash flows for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
BioHiTech Global Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow0.2M0.1M0.45M0.33M0.2M0.09M0.36M0.26M--
Net Increase (Decrease) in Assets Liabilities0.69M0.47M0.08M0.34M-0.26M-0.18M1.43M0.85M--
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.86M0.51M1.01M0.63M0.41M0.12M0.03M-0.21M--
BioHiTech Global Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment0.01M0.01M-0.01M----0.01M-0.11M--
Acquisition Disposition of Subsidiaires------0.07M0.07M--
Increase (Decrease) in Investments-1.03M-1.03M--------
Other Cash Inflow (Outflow) from Investment Activities-0.07M-0.03M--------
BioHiTech Global Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities3.07M1.99M5.64M3.92M3.3M1.77M3.08M2.27M0.02M0.01M
Increase (Decrease) in Bank & Other Borrowings---0.02M-0.02M-0.02M-0.02M0.03M---
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.02M-0.01M-0.19M-0.16M-0.13M-0.08M----
BioHiTech Global Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash0.02M-0.05M0.06M0.02M0.01M-0.01M---
BioHiTech Global Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year0.03M0.04M--------
Cash & Equivalents at Year End0.15M0.32M0.32M0.17M0.23M0.13M0.03M0.04M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

BioHiTech Global stock comparison chart provides an easy way to compare the stock price with peers along with details of BioHiTech Global stock price history.
The statement of cash flows can be categorized into three main sections:
  • BioHiTech Global has cash of $0.15M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the BioHiTech Global stock price.
  • Cash Flow from operating activities: BioHiTech Global reported a negative operating cash flow of $-2.15M for 2017-Q2 and has seen a decrease from the previous quarter. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $-2.15M for BHTG in last quarter report.
  • Cash flow from financing activities shows the flow of cash between BioHiTech Global and its owners and creditors and was $3.06M for 2017-Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For BioHiTech Global Cash Flow

FCF margin